For women navigating fertility after 35, an unexpected diagnosis like Asherman’s syndrome can feel disorienting, especially when it surfaces during a fertility workup that was already emotionally demanding. Asherman’s syndrome refers to the formation of scar tissue, or adhesions, inside the uterine cavity, most often following a prior uterine procedure such as a dilation and curettage (D&C).
While the condition is relatively uncommon, understanding what it is, how it’s diagnosed, and what treatment options exist can help provide clarity during what is often an uncertain part of the fertility journey.
It can also help to know that fertility clinics increasingly screen for uterine cavity abnormalities, including adhesions, as a standard part of a fertility workup after unexplained difficulty conceiving or recurrent loss. This means Asherman’s syndrome is often identified earlier in the process than it might have been in the past, allowing treatment to begin before extensive time has passed.
What Research Shows About Asherman’s Syndrome
Research published through the National Institutes of Health indicates that intrauterine adhesions are most frequently associated with procedures performed after miscarriage, postpartum hemorrhage, or elective termination, particularly when performed close in time to pregnancy. The severity of scarring can range from mild, thin adhesions to more extensive scarring that significantly reduces the uterine cavity’s functional space.
Because symptoms can be subtle — sometimes limited to lighter-than-usual periods or absent periods — the condition is sometimes discovered only after a woman experiences difficulty conceiving or has recurrent pregnancy loss.
How Asherman’s Syndrome Is Diagnosed
Diagnosis typically involves imaging or direct visualization of the uterine cavity. A hysterosalpingogram (HSG), saline infusion sonogram, or hysteroscopy are the tools most often used to identify and characterize adhesions. Many fertility specialists consider hysteroscopy the most definitive method, since it allows for both diagnosis and, in many cases, treatment within the same procedure.
Why This Matters for Women Trying to Conceive After 35
Because fertility already involves multiple age-related considerations after 35, an additional structural factor like uterine scarring can understandably feel discouraging. It’s worth remembering that Asherman’s syndrome is a treatable condition in many cases, and a diagnosis doesn’t necessarily mean conception isn’t possible with appropriate care.
Treatment Approaches
Hysteroscopic adhesiolysis — the surgical removal of scar tissue using a hysteroscope — is the most common treatment approach. Following the procedure, some providers recommend a course of estrogen therapy to support the regrowth of healthy uterine lining, along with a follow-up procedure to confirm the adhesions have not reformed. Outcomes vary depending on the severity of the original scarring, and some women require more than one procedure.
Because treatment and recovery timelines can affect broader fertility planning, many women find it helpful to discuss Asherman’s syndrome alongside other elements of their care, including topics like hysterosalpingogram testing and overall fertility evaluation timelines.
Emotional Considerations
Receiving a diagnosis tied to a previous pregnancy loss or procedure can bring up complicated feelings. Many women describe a mix of relief at having an explanation and grief connected to the circumstances that led to the scarring in the first place. Connecting with a therapist experienced in reproductive health, or a support community focused on the emotional weight of trying to conceive, can be a valuable part of the process alongside medical treatment.
Risk Factors Worth Understanding
While any uterine procedure carries some risk of adhesion formation, research suggests that certain circumstances are associated with higher likelihood, including procedures performed shortly after a pregnancy, multiple procedures over time, or infection following a uterine procedure. Understanding your own procedural history — including how many dilation and curettage procedures you’ve had and under what circumstances — can help your fertility specialist assess your individual risk profile and determine appropriate evaluation.
It’s worth noting that many women who have had a D&C never develop clinically significant adhesions, and having one or more prior procedures does not automatically mean Asherman’s syndrome will develop. The condition is thought to affect a relatively small subset of women who undergo these procedures, though exact prevalence estimates vary across studies due to differences in diagnostic criteria and study populations.
What Happens During and After Hysteroscopic Treatment
During hysteroscopic adhesiolysis, a thin, lighted instrument is inserted through the cervix, allowing the surgeon to directly visualize and carefully remove scar tissue while preserving as much healthy uterine lining as possible. The procedure is typically performed on an outpatient basis, with most women resuming normal activities within a few days.
After treatment, some providers use a temporary device, such as a small balloon or intrauterine device, to help keep the uterine walls separated while the lining heals, reducing the likelihood that adhesions will reform. Estrogen therapy is often prescribed during this healing period to encourage regrowth of healthy tissue. A follow-up hysteroscopy or imaging study is commonly scheduled several weeks later to confirm the results before moving forward with conception attempts or fertility treatment.
Looking Ahead After Treatment
Many women who complete treatment for Asherman’s syndrome go on to work with their fertility team to plan next steps, whether that means attempting natural conception, moving forward with intrauterine insemination, or proceeding to IVF depending on other fertility factors already in play. Because age-related fertility considerations continue alongside any structural treatment, some specialists recommend not delaying additional fertility evaluation while adhesion treatment is underway, so that a comprehensive picture is available once the uterine cavity has healed. Patience during this process can be difficult, particularly for women who feel they are already working against a timeline, but taking the necessary time for proper healing is generally considered important for improving the odds of a successful, healthy pregnancy once conception attempts resume.
Frequently Asked Questions
Does Asherman’s syndrome mean I can’t get pregnant?
Not necessarily. Many women who undergo treatment for intrauterine adhesions go on to conceive, though outcomes depend on the extent of scarring and individual response to treatment. Your fertility specialist can offer guidance specific to your situation.
Is Asherman’s syndrome more common after 35?
The condition itself is not clearly linked to age, but women who have had more uterine procedures over time — which can become more likely with age or additional pregnancies — may have a higher cumulative risk.
How long does treatment take before trying to conceive again?
Recovery timelines vary by individual and severity, and your provider will typically recommend a specific waiting period and possibly a follow-up procedure to confirm healing before proceeding with conception attempts.
Can adhesions come back after treatment?
Recurrence is possible, particularly with more severe initial scarring, which is why many providers recommend follow-up monitoring after treatment.
What questions should I ask my fertility specialist about treatment?
Helpful questions include asking about the extent of scarring found during diagnosis, the expected number of procedures needed, the recommended waiting period before trying to conceive, and how success will be monitored going forward.
Key Takeaways
- Asherman’s syndrome involves scar tissue inside the uterine cavity, most often linked to a prior uterine procedure.
- Diagnosis typically involves imaging or hysteroscopy, and treatment often involves hysteroscopic removal of the adhesions.
- Many women conceive after treatment, though outcomes vary based on scarring severity.
- Working with a reproductive endocrinologist can help clarify next steps and realistic expectations.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.